Redpoint Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $585K | Buy |
2,921
+431
| +17% | +$86.3K | 0.09% | 286 |
|
|
2022
Q2 | $363K | Hold |
2,490
| – | – | 0.04% | 455 |
|
|
2022
Q1 | $407K | Hold |
2,490
| – | – | 0.04% | 481 |
|
|
2021
Q4 | $422K | Hold |
2,490
| – | – | 0.03% | 492 |
|
|
2021
Q3 | $470K | Hold |
2,490
| – | – | 0.04% | 464 |
|
|
2021
Q2 | $422K | Hold |
2,490
| – | – | 0.03% | 504 |
|
|
2021
Q1 | $352K | Hold |
2,490
| – | – | 0.03% | 531 |
|
|
2020
Q4 | $324K | Hold |
2,490
| – | – | 0.03% | 464 |
|
|
2020
Q3 | $363K | Buy |
2,490
+789
| +46% | +$115K | 0.04% | 433 |
|
|
2020
Q2 | $252K | Buy |
+1,701
| New | +$252K | 0.01% | 522 |
|